DOCSLIB.ORG

Esophageal Varices Bleeding in Portal Hypertension Due to Portal Vein and Splenic Vein Obstruction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Esophageal Varices Bleeding in Portal Hypertension Due to Portal Vein and Splenic Vein Obstruction CASE REPORT Esophageal Varices Bleeding in Portal Hypertension due to Portal Vein and Splenic Vein Obstruction David R.S. Samosir*, Loli Simanjuntak*, Bambang Setiyohadi**, L.A. Lesmana***, Aru W. Sudoyo****, Marcellus Simadibrata***** * Department of Internal Medicine, Faculty of Medicine, University of Indonesia/ Cipto Mangunkusumo Hospital, Jakarta ** Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta *** Division of Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta **** Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta ***** Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta ABSTRACT Based on its relation to the liver sinusoid, increased pressure of portal vein can occur at three levels: presinusoid, sinusoid ,and postsinusoid. Obstruction of the presinusoid veins can be caused by extra-he- patic condition such as venous thrombosis. We reported a case of portal hypertension with esophageal varices bleeding was a result of obstruction due to thrombosis of the splenic vein and portal vein under hypercoagulant conditions due to thrombocyto- sis. The management of esophageal varices was sclerotherapy while for overcome the thrombosis the patient was given hydroxy urea. Key Words: Esophageal varices bleeding, portal hypertension, vein obstruction INTRODUCTION Liver cirrhosis is the most common disease that Portal hypertension is defined as increased portal vein causes portal hypertension. Portal vein obstruction is the second most common cause, which can be idiopathic or pressure of over 30 cmH20, often caused by increased pressure on the portal blood flow. Based on its relation may be related to liver cirrhosis, infection, abdominal to the liver sinusoid, increased pressure can occur at trauma, congenital malformations of the portal vein, post- three levels, presinusoid, sinusoid, and postsinusoid. Ob- surgical conditions, autoimmune diseases, changes in the struction of the presinusoid veins can anatomically be walls of the portal vein due to inflammation, malignancy, caused by extra-hepatic conditions (such as venous pancreatic disorders, etc.1,3,4,5,6 Pancreatic disorders may thrombosis and increased splenic blood flow), or at the take the form of pancreatitis, carcinoma, and cysts.3 proximal of the liver sinusoid, preventing the liver paren- Pancreatic cysts may take the form of pseudocysts, se- chyme from exposure towards increased venous pres- rous cystadenoma, mucinous cyst neoplasm, and muci- sure (such as schistosomiasis). Postsinusoidal obstruc- nous cystadenocarcinoma.7 Malignant disorders may tion may be caused by the Budd-Chiari syndrome and cause portal vein thrombosis through direct invasion of veno-occlusive diseases. Cirrhosis causes portal hyper- the portal vein, external compression of the portal vein, tension at the sinusoid level.1,2,3 or periportal fibrosis due to surgery or radiotherapy. 24 The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy Esophageal Varices Bleeding in Portal Hypertension due to Portal Vein and Splenic Vein Obstruction Chronic pancreatitis is often accompanied by splenic vein Red Cross Hospital, Bogor, for one week and received thrombosis.4 3 kinds of medications. The patient was released when Venous obstruction may also be caused by thrombo- he was relieved of his symptoms. sis under hypercoagulant conditions, such as venous Ten months following admission there was swelling policytemia, thrombocytosis, or deficiency of protein C, of the upper left abdomen, sometimes accompanied by protein S, or antithrombin III. Thrombocytosis can be intense pain, which recurred and did not spread. The primary (in myeloproliferative conditions) or secondary patient was readmitted to the Red Cross Hospital. (such as in iron deficiency anemia, chronic inflamma- Three months following the second admission, the tory diseases, post-surgical conditions, malignancy, and patient vomited and defecated black stool. The patient so forth). 1,3,6,8 was admitted for the third time to the Red Cross Hospi- Clinical manifestations of portal hypertension include tal. He received 10 packages of red transfusion and 4 abdominal discomfort, gastric and esophageal varices packs of yellowish transfusion. The patient was advised bleeding, splenomegaly, hypersplenism, ascites, and acute to be treated at Cipto Mangunkusumo Hospital. The and chronic encephalopathy if severe. Under non-cir- patient denied any history of alcoholism, herb drinking, rhotic conditions, patients with splenomegaly with va- and smoking. The patient often suffered from general- riceal bleeding should be suspected of splenic vein or ized weakness. portal vein thrombosis. 1,3,8,9 Normal liver biopsy may During physical examination, we found the patient to demonstrate mild changes in portal hypertension due to be moderately ill, fully conscious, with a blood pressure extra-hepatic portal vein obstruction. 5, 10, 11 Radiologic of 110/70 mmHg, a pulse rate of 90 times/minute, a tem- imaging such as ultra-sonography, Computerized Tomog- perature of 37°C, and a respiratory rate of 20 times/ raphy Scan (CT-scan), Magnetic Resonance Imaging minute. His conjunctiva were not pale. His sclera showed (MRI), angiography, and splenoportography may assist no signs of jaundice. His jugular venous pressure was 5- the investigation of the cause of portal vein obstruction. 2 cm H2O. His lungs were sonor, vesicular, without and 3, 4, 8 rales/crackles or wheezing. First and second heart Treatment is usually aimed at alleviation of the com- sounds were pure, without any gallop or murmur. His plications of portal hypertension. Bleeding must be con- abdomen was not distended. His liver was not palpable. trolled. Avoid administration of aspirin. Somatostatin and His spleen was palpable at Schuffner III, pliant, smooth, sclerotherapy may be used.3,12 If bleeding has been with rounded edges and without tenderness. No mass managed, investigate the cause of portal hypertension. was palpable. There was no lymph node enlargement. If esophageal varices bleeding is caused by portal vein There was no palmar erythema and spider nevi. thrombosis due to thrombocytosis, reduction of platelet Laboratory findings were as follows: Hemoglobin count by means of cytotoxic drugs is more advisable level 11,2 g/dL, Hematocryte 38 vol %, leukocyte count than surgery.4 Beta-adrenergic blockers such as 27.800/mL, platelet count 1.499.000/mL, LED 10 mm/ propanolol or nadolol, in addition to being capable of re- hour. Urine evaluation findings were as follows: specific ducing portal pressure through a vasodilatation effect on gravity 1020, pH 6, leukocyte count 4-5/LPB. No eryth- the splancnic arterial flow and the portal vein system, in rocyte was found in the urine. The patient’s albumin level addition to by reducing cardiac output. Splenectomy is was 4,7 g/dL, his globulin level 3,3 g/dL, and total biliru- indicated in excessively large spleens, hypersplenism, and bin 0,5 mg/dL. obstruction of the splenic vein. 1, 2, 3 Chest x-ray demonstrated a cardiothoracic ratio (CTR) of less than 50%. There was no infiltrates in the CASE REPORT lungs. Mr. S, 52 years old, middle class, was hospitalized on During admission, the following problems were es- the fourth floor of the B in-patient ward of Cipto tablished: 1. Splenomegaly, 2. Anemia, 3. Thrombocyto- Mangunkusumo Hospital from the 28th of May, 1999, sis and leukocytosis. due to complaints of pain on the upper left abdomen since During further evaluation, abdominal ultrasound dem- 1 year prior to hospital admission. The pain was sudden onstrated chronic hepatitis with multiple pancreatic cysts in nature, recurrent, did not spread and was so severe and splenomegaly. Abdominal CT-scan without contrast that the patient was unable to walk. There was no nau- demonstrated mass on the pancreatic head and splenom- sea and vomiting, and there was no fever. The patient egaly. Abdominal CT-scan using contrast demonstrated defecated as usual. The patient was hospitalized at the splenomegaly, chronic liver disease, and suspected tu- Volume 3, Number 1, April 2002 25 David R.S. Samosir, Loli Simanjuntak, Bambang Setiyohadi, L.A. Lesmana, Aru W. Sudoyo, Marcellus Simadibrata mor of the pancreatic head with a differential diagnosis DISCUSSION of pancreatitis and carcinoma of the pancreatic head. Absence of cirrhosis during liver biopsy demonstrated Blood amylase level was 241 S. Somogryi (Normal: 90- that in this case, portal hypertension is a result of ob- 150) and his blood lipase level was 250 U/I (Normal: struction of the splenic vein and the portal vein, due to <190). His CA was 19-9: 31 U/mL (Normal: <35). Dop- thrombosis of the splenic vein and portal vein under pler ultrasound demonstrated increased portal vein pres- hypercoagulant conditions due to thrombocytosis. There sure, with a suspicion towards portal vein thrombosis. is also the possibility of obstruction due to fibrosis of the Liver biopsy demonstrated an image that was in line with pancreas, infiltrating the walls of the splenic vein, caus- chronic hepatitis, with a differential diagnosis of liver ing thrombus or cystic tumor of the pancreatic head, without significant disorder. The cause of portal hyper- obstructing the portal
Load more

Recommended publications
  • Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: a Review
    micromachines Review Engineered Liver-On-A-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review 1, 1, 2, 1, 1 Jiu Deng y, Wenbo Wei y, Zongzheng Chen y , Bingcheng Lin *, Weijie Zhao , Yong Luo 1 and Xiuli Zhang 3,* 1 State Key Laboratory of Fine Chemicals, Department of Chemical Engineering, Dalian University of Technology, Dalian 116024, China; [email protected] (J.D.); [email protected] (W.W.); [email protected] (W.Z.); [email protected] (Y.L.) 2 Integrated Chinese and Western Medicine Postdoctoral research station, Jinan University, Guangzhou 510632, China; [email protected] 3 College of Pharmaceutical Science, Soochow University, Suzhou 215123, China * Correspondence: [email protected] (B.L.); [email protected] (X.Z.); Tel.: +86-0411-8437-9065 (B.L.); +86-155-0425-7723 (X.Z.) These authors have equally contribution to this work. y Received: 17 September 2019; Accepted: 3 October 2019; Published: 7 October 2019 Abstract: Hepatology and drug development for liver diseases require in vitro liver models. Typical models include 2D planar primary hepatocytes, hepatocyte spheroids, hepatocyte organoids, and liver-on-a-chip. Liver-on-a-chip has emerged as the mainstream model for drug development because it recapitulates the liver microenvironment and has good assay robustness such as reproducibility. Liver-on-a-chip with human primary cells can potentially correlate clinical testing. Liver-on-a-chip can not only predict drug hepatotoxicity and drug metabolism, but also connect other artificial organs on the chip for a human-on-a-chip, which can reflect the overall effect of a drug.
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Analysis of the Sinusoidal Endothelial Cell Organization During The
    CELL STRUCTURE AND FUNCTION 23: 341-348 (1998) © 1998 by Japan Society for Cell Biology Analysis of the Sinusoidal Endothelial Cell Organization during the Develop- mental Stage of the Fetal Rat Liver Using a Sinusoidal Endothelial Cell Specific Antibody, SE-1 Mamoru Morita1, Wang Qun2, Hitoshi Watanabe1, Yuko Doi1, Michio Mori3, and Katsuhiko Enomoto1'* department of Pathology, Akita University School of Medicine, Hondo, Akita 010-8543, Japan, depart- ment of Pathology, School of Basic Medicine, NormanBethune University of Medical Science, Jilin, P.R. of China, and *Department of Pathology, Sapporo Medical University School of Medicine, S-l, W-17, Chuo-ku, Sapporo 060, Japan Keywords: sinusoidal endothelial cells/SE-1 antibody/fetal rat liver ABSTRACT.The sinusoid organization during the development of fetal rat livers was studied using a SE-1 antibody, which we have previously established as a specific monoclonal antibody against rat sinusoidal endo- thelial cell (SEC). Expression and localization of the SE-1 antigen in the liver tissues of 13- to 21-day-old fe- tuses were immunofluorescently and immunoelectron microscopically examined. The first positive fluorescence was observed in the immature liver of 15-day-old fetuses. The initial positive staining was randomly distrib- uted in the liver parenchyma and showed no direct relation to the large vessels which may be derived from the fetal vitelline veins. The positive linear staining increased in number and connected with each other during the course of development. The SE-1 staining pattern and the sinusoidal arrangement became similar to those of the adult liver after 20th day of gestation. Immunoelectron microscopically, the immature SEC showed a weak positive reaction for the SE-1 antigen at their membraneand was observed together with immature hepato- cytes and hematopoietic cells in the 15-day-old fetal liver.
    [Show full text]
  • Title of My Thesis
    Development of an in vitro 3D Printed Liver Sinusoid Model Soumya Sethi A Dissertation Submitted to Indian Institute of Technology Hyderabad In Partial Fulfillment of the Requirements for The Degree of Master of Technology Department of Biomedical Engineering June, 2018 Declaration I declare that this written submission represents my ideas in my own words, and where others’ ideas or words have been included, I have adequately cited and referenced the original sources. I also declare that I have adhered to all principles of academic honesty and integrity and have not misrepresented or fabricated or falsified any idea/data/fact/source in my submission. I understand that any violation of the above will be a cause for disciplinary action by the Institute and can also evoke penal action from the sources that have thus not been properly cited, or from whom proper permission has not been taken when needed. (Signature) Soumya Sethi BM16MTECH11007 (Roll No) ii Approval Sheet iii Acknowledgements I would like to thank my thesis supervisor Dr Falguni Pati for his continuous guidance. I would also like to thank my lab members especially Shibu Chameettachal, Shyama Sasikumar, Sriya for supporting me and helping me out whenever required. They have been a continuous source of inspiration for me, without their passionate participation and inputs, the project could not have been successfully conducted. iv Abstract Liver is one of the most remarkable organs of the human body as it performs various vital functions namely metabolism of fats and carbohydrates, drugs, detoxification, production of bile and has a capacity to regenerate. The intricate functional units of the liver called the sinusoids are of immense interest as they are early targets of many drugs and toxicants as well as have been reported to play a significant role in initiating liver regeneration and contribute to the pathophysiology of many liver diseases.
    [Show full text]
  • Elimination Pathways of Nanoparticles † ‡ † ‡ ◆ † ‡ § ◆ † ‡ † ‡ Wilson Poon, , Yi-Nan Zhang, , , Ben Ouyang, , , , Benjamin R
    Article Cite This: ACS Nano 2019, 13, 5785−5798 www.acsnano.org Elimination Pathways of Nanoparticles † ‡ † ‡ ◆ † ‡ § ◆ † ‡ † ‡ Wilson Poon, , Yi-Nan Zhang, , , Ben Ouyang, , , , Benjamin R. Kingston, , Jamie L. Y. Wu, , ∥ ⊥ † ‡ # ∇ ○ Stefan Wilhelm, , and Warren C. W. Chan*, , , , , † Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada ‡ Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada § MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada ∥ Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma 73019, United States ⊥ Stephenson Cancer Center, Oklahoma City, Oklahoma 73104, United States # Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario M5S 3E5, Canada ∇ Department of Materials Science and Engineering, University of Toronto, Toronto, Ontario M5S 1A1, Canada ○ Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada *S Supporting Information ABSTRACT: Understanding how nanoparticles are eliminated from the body is required for their successful clinical translation. Many promising nanoparticle formulations for in vivo medical applications are large (>5.5 nm) and nonbiodegradable, so they cannot be eliminated renally. A proposed pathway for these nanoparticles is hepatobiliary from https://pubs.acs.org/doi/10.1021/acsnano.9b01383. elimination, but their transport has
    [Show full text]
  • The Influence of Chronic Liver Diseases on Hepatic Vasculature
    micromachines Review The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review Alican Özkan 1,* , Danielle Stolley 2, Erik N. K. Cressman 3 , Matthew McMillin 4,5 , Sharon DeMorrow 4,5,6 , Thomas E. Yankeelov 2,7,8,9,10 and Marissa Nichole Rylander 1,2,7 1 Department of Mechanical Engineering, The University of Texas, Austin, TX 78712, USA; [email protected] 2 Department of Biomedical Engineering, The University of Texas, Austin, TX 78712, USA; [email protected] (D.S.); [email protected] (T.E.Y.) 3 Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; [email protected] 4 Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78713, USA; [email protected] (M.M.); [email protected] (S.D.) 5 Central Texas Veterans Health Care System, Temple, TX 76504, USA 6 Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA 7 Oden Institute for Computational Engineering and Sciences, The University of Texas, Austin, TX 78712, USA 8 Departments of Diagnostic Medicine, The University of Texas, Austin, TX 78712, USA 9 Department of Oncology, The University of Texas, Austin, TX 78712, USA 10 Livestrong Cancer Institutes, Dell Medical School, The University of Texas, Austin, TX 78712, USA * Correspondence: [email protected]; Tel.: +1-512-806-9062 Received: 16 April 2020; Accepted: 4 May 2020; Published: 9 May 2020 Abstract: In chronic liver diseases and hepatocellular carcinoma, the cells and extracellular matrix of the liver undergo significant alteration in response to chronic injury.
    [Show full text]
  • Original Article Rat Liver Sinusoidal Dilatation Induced by Perfusion In
    Int J Clin Exp Med 2016;9(6):11284-11291 www.ijcem.com /ISSN:1940-5901/IJCEM0021986 Original Article Rat liver sinusoidal dilatation induced by perfusion in vitro through portal vein alone, hepatic artery alone, and portal vein together with hepatic artery Hefang Shen1, Jing Dong1, Lingling Xia2, Jianjian Xu3, Lili Xu1 1School of Basic Medical Science, Anhui Medical University, Hefei, Anhui 230032, People’s Republic of China; 2Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Anhui, People’s Republic of China; 3School of Medical Engineering, Hefei University of Technology, Hefei, Anhui 230009, People’s Republic of China Received December 15, 2015; Accepted February 4, 2016; Epub June 15, 2016; Published June 30, 2016 Abstract: The techniques for liver perfusion have been recommended in order to protect liver grafts prior to trans- plantation. We compared portal vein alone, hepatic artery alone, and dual perfusion through portal vein together with hepatic artery perfusion techniques in rat livers analyzed in histology. Rat livers were treated for 30 min in situ warm ischemia and excised and directly placed to mimic conventional cold storage for 4 hours followed by different routes of cold perfusion. In three experimental groups, five livers were given portal vein perfusion in group one. In group two, five livers were subjected to hepatic artery perfusion and in group three five livers received both portal vein and hepatic artery perfusion. Histological samples were taken before the beginning of the perfusion, 30 min- utes, and 60 minutes after starting of the perfusion. Rat livers, received portal vein perfusion in group one, revealed remarkable sinusoidal dilatation increasingly with augmented perfusion time.
    [Show full text]
  • 26 April 2010 TE Prepublication Page 1 Nomina Generalia General Terms
    26 April 2010 TE PrePublication Page 1 Nomina generalia General terms E1.0.0.0.0.0.1 Modus reproductionis Reproductive mode E1.0.0.0.0.0.2 Reproductio sexualis Sexual reproduction E1.0.0.0.0.0.3 Viviparitas Viviparity E1.0.0.0.0.0.4 Heterogamia Heterogamy E1.0.0.0.0.0.5 Endogamia Endogamy E1.0.0.0.0.0.6 Sequentia reproductionis Reproductive sequence E1.0.0.0.0.0.7 Ovulatio Ovulation E1.0.0.0.0.0.8 Erectio Erection E1.0.0.0.0.0.9 Coitus Coitus; Sexual intercourse E1.0.0.0.0.0.10 Ejaculatio1 Ejaculation E1.0.0.0.0.0.11 Emissio Emission E1.0.0.0.0.0.12 Ejaculatio vera Ejaculation proper E1.0.0.0.0.0.13 Semen Semen; Ejaculate E1.0.0.0.0.0.14 Inseminatio Insemination E1.0.0.0.0.0.15 Fertilisatio Fertilization E1.0.0.0.0.0.16 Fecundatio Fecundation; Impregnation E1.0.0.0.0.0.17 Superfecundatio Superfecundation E1.0.0.0.0.0.18 Superimpregnatio Superimpregnation E1.0.0.0.0.0.19 Superfetatio Superfetation E1.0.0.0.0.0.20 Ontogenesis Ontogeny E1.0.0.0.0.0.21 Ontogenesis praenatalis Prenatal ontogeny E1.0.0.0.0.0.22 Tempus praenatale; Tempus gestationis Prenatal period; Gestation period E1.0.0.0.0.0.23 Vita praenatalis Prenatal life E1.0.0.0.0.0.24 Vita intrauterina Intra-uterine life E1.0.0.0.0.0.25 Embryogenesis2 Embryogenesis; Embryogeny E1.0.0.0.0.0.26 Fetogenesis3 Fetogenesis E1.0.0.0.0.0.27 Tempus natale Birth period E1.0.0.0.0.0.28 Ontogenesis postnatalis Postnatal ontogeny E1.0.0.0.0.0.29 Vita postnatalis Postnatal life E1.0.1.0.0.0.1 Mensurae embryonicae et fetales4 Embryonic and fetal measurements E1.0.1.0.0.0.2 Aetas a fecundatione5 Fertilization
    [Show full text]
  • Hepatic Sinusoidal Endothelial Cells 5
    CHAPTER 5 Hepatic Sinusoidal Endothelial Cells 5 Roman E. Perri, Vijay Shah 5.1 Development and Structure Hepatic sinusoidal endothelial cells (HSEC) are a morphologically distinct population of cells that form the lining of liver sinusoids. Features that dis- tinguish HSEC from endothelial cells in other or- gans and in larger liver vessels are the presence of multiple fenestrae throughout the cells and the lack of an underlying basement membrane [3, 7, 60, 72]. The sinusoids are positioned between hepato- cyte plates and initiate at the portal tract and termi- nate at the central vein. Sinusoids carry blood that converges in the liver from the portal venous sup- ply, as well as from the hepatic artery [76] (Fig. 5.1). Sinusoids are separated from adjacent hepatocytes by the perisinusoidal space, also known as the space of Disse. Due to their position, HSEC are the first cells in contact with blood flow into the sinusoids and serve to compartmentalize the vascular sinu- soidal channels from the hepatic parenchyma [60, 72]. The hepatic sinusoids range in diameter from Fig. 5.1. Vasculature architecture of the liver. Blood flow enters 4 µm near the portal triad to 5.5 µm near the cen- the liver via the portal vein (PVb) as well as the hepatic artery tral vein [30]. Because they are smaller than both (HAb). While portal blood enters directly into the sinusoids (S), red and white blood cells, there is distortion of both hepatic arterial blood perfuses into distinct anatomic locations cells and the sinusoids during passage of blood cells prior to re-entering the sinusoids.
    [Show full text]
  • Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure
    International Journal of Molecular Sciences Review Critical Role of LSEC in Post-Hepatectomy Liver Regeneration and Failure Maxime De Rudder 1, Alexandra Dili 1,2, Peter Stärkel 1,3 and Isabelle A. Leclercq 1,* 1 Laboratory of Hepato-Gastroenterology, Institute of Experimental and Clinical Research, UCLouvain, 1200 Brussels, Belgium; [email protected] (M.D.R.); [email protected] (A.D.); [email protected] (P.S.) 2 HPB Surgery Unit, Centre Hospitalier Universitaire UCL Namur, Site Mont-Godinne, 5530 Yvoir, Belgium 3 Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium * Correspondence: [email protected]; Tel.: +32-2-764-5273 Abstract: Liver sinusoids are lined by liver sinusoidal endothelial cells (LSEC), which represent approximately 15 to 20% of the liver cells, but only 3% of the total liver volume. LSEC have unique functions, such as fluid filtration, blood vessel tone modulation, blood clotting, inflammatory cell recruitment, and metabolite and hormone trafficking. Different subtypes of liver endothelial cells are also known to control liver zonation and hepatocyte function. Here, we have reviewed the origin of LSEC, the different subtypes identified in the liver, as well as their renewal during homeostasis. The liver has the exceptional ability to regenerate from small remnants. The past decades have seen increasing awareness in the role of non-parenchymal cells in liver regeneration despite not being the most represented population. While a lot of knowledge has emerged, clarification is needed regarding the role of LSEC in sensing shear stress and on their participation in the inductive phase of regeneration by priming the hepatocytes and delivering mitogenic factors.
    [Show full text]
  • Experimentally Impeded Are Described. Vision
    Br. J. exp. Path. (1976) 57, 604 EFFECT OF HEPATIC VENOUS OUTFLOW OBSTRUCTION ON PORES AND FENESTRATIONS IN SINUSOIDAL ENDOTHELIUM* W. NOPANITAYA, J. C. LAMB, J. W. GRISHAMI AND J. L. CARSON Fromn the Department of Pathology, School of MIedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514 Received( for publication Junie 15, 1976 Summary.-The ultrastructure of pores and fenestrations in hepatic sinusoidal endothelial cells was examined following partial surgical occlusion of the supra- hepatic portion of the inferior vena cava. Within 12 h after partial obstruction of hepatic venous outflow, endothelial pores ( < 0-1 [km in diameter) and sieve plates in the distal halves of sinusoids were greatly reduced in number or were totally absent, and they were replaced by large fenestrations ( < 1 0 um in diameter). These results suggest that pores forming sieve plates may fuse to form large fenestrations. The findings also indicate that sinusoidal hypertension and hypoxia associated with obstruction of hepatic venous outflow alter the distribution of pores and fenestrations in sinusoidal endothelium. THE ultrastructure of hepatic sinusoidal MATERIALS AND METHODS endothelial cells of several species recently Experiments were carried out oni female has been established by studies employing Wlistar albino rats. The animals were retired transmission (TEM) and scanning (SEM) breeders weighing approximately 325 g. They electron microscopy (Fawcett, 1955; Bruni were kept in wire bottom cages and fed Purina laboratory chow and tap water ad libitum for at and Porter, 1965; Wisse, 1970; Orci, least 3 weeks before being used for this study. Matter and Rouiller, 1971; Ogawa et al., All animals were anaesthetized by injecting 1973; Brooks and Haggis, 1973; Motta and sodium pentobarbital (5 mg/100 g body weight) Porter, 1974; Motta, 1975; Grisham et al., i.p.
    [Show full text]
  • Hepatic Artery
    Ingegneria delle tecnologie per la salute Fondamenti di anatomia e istologia aa. 2019-20 Lesson 7. Digestive system and peritoneum Liver • hepatic artery delivers oxygenated blood from heart to liver, hepatic portal vein delivers partially deoxygenated blood containing nutrients (+ drugs and toxins) absorbed from the small intestine and actually supplies more oxygen to liver than do much smaller hepatic arteries; after processing bloodborne nutrients and toxins, liver releases nutrients needed by other cells back into the blood, which drains into central vein and then through hepatic vein to inferior vena cava. • hepatic portal circulation = all blood from alimentary canal passes through liver (explaining liver most common site for alimentary canal cancers metastasis) Liver: Histology = 3 main components: 1 hepatocytes [liver’s main cell type, accounting for around 80% of liver's volume, playing a role in a wide variety of secretory, metabolic, and endocrine functions; plates of hepatocytes called hepatic laminae radiate outward from portal vein in each hepatic lobule] = from their central position, hepatocytes process nutrients, toxins, and waste materials carried by blood: materials such as bilirubin processed and excreted into bile canaliculi, other materials including proteins, lipids, and carbohydrates processed and secreted into sinusoids or just stored in cells until called upon. Liver: Histology = 3 main components: 2 bile canaliculi [grooves in cell membranes between adjacent hepatocytes accumulating bile produced by hepatocytes:
    [Show full text]